NOTE PURCHASE AGREEMENT

Amendments

1. Aug 21, 2026

   Amendmentunconfirmed

   Adds a $4,000,000 fourth advance and a $2,000,000 fifth advance under the note purchase, and amends conditions to the fifth closing. The Business Combination Deadline is moved to October 31, 2026, additional expense reimbursements of $25,000 at the fourth closing and up to $25,000 at the fifth closing are provided, and the Investor is assured an aggregate of 1,000,000 surviving entity shares.

   • fourth_tranche_advance: n/a → 4000000 §1(a)
   • fifth_tranche_advance: n/a → 2000000 §1(a)
   • Business Combination Deadline: n/a → 2026-10-31 §1(d)
   • Fifth Closing condition: Business Combination outside date: n/a → 2026-10-31 §1(c)
   • additional_expense_reimbursement_fourth_closing: n/a → 25000 §1(e)
   • additional_expense_reimbursement_fifth_closing_cap: n/a → 25000 §1(e)
   • Aggregate Surviving Entity Shares: n/a → 1000000 §1(b)

   Filing ↗

2. Aug 21, 2026

   Amendment

   Amendment No. 1 modifies the existing Note Purchase Agreement as shown in the attached conformed copy with blackline changes. Its effectiveness is conditioned on delivery of executed signatures to this amendment and to an Amended and Restated Convertible Promissory Note by the Company and identified pledging stockholders.

   Filing ↗